Skip to content

Experience Sampling Method for Symptom Assessment in Irritable Bowel Syndrome

Development and Validation of a Real-time Patient-Reported Outcome Measure for Chronic Abdominal Pain: The Experience Sampling Method (ESM)

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02880722
Enrollment
184
Registered
2016-08-26
Start date
2016-10-31
Completion date
2022-05-01
Last updated
2022-05-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Irritable Bowel Syndrome

Keywords

Irritable Bowel Syndrome (IBS), Experience Sampling Method (ESM), Ecological Momentary Assessment (EMA), Abdominal pain

Brief summary

Reliable patient reported outcome measures (PROM's) for symptom assessment in irritable bowel syndrome are essential in order to investigate natural disease course and potential treatment options aimed at symptom improvement, since biological markers are currently unavailable. Currently used symptom assessment methods, i.e. end-of-day or end-of-week questionnaires, have considerable limitations. The Experience Sampling Method (ESM), an electronic questioning method characterized by random and repeated, momentary assessments in the subject's current state and environment, might overcome these limitations. Aim of this study is to validate an IBS-specific electronic patient-reported outcome measure, based on the Experience Sampling Method-principle, for symptom assessment in IBS.

Interventions

None listed

Sponsors

Grünenthal GmbH
CollaboratorINDUSTRY
Maastricht University Medical Center
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
Yes

Inclusion criteria

* Diagnosis of irritable bowel syndrome according to Rome IV criteria. * Ability to understand and speak the national language of the concerning center. * Ability to understand how to utilize the ESM-tool.

Exclusion criteria

* Any organic explanation for the abdominal complaints. * A history of abdominal surgery, except for uncomplicated appendectomy, laparoscopic cholecystectomy and hysterectomy. * Start up of regularly used medication from one month before inclusion until the end of study participation.

Design outcomes

Primary

MeasureTime frameDescription
Abdominal pain scores as measured by the ESM tool.7 daysMomentary measurements.

Secondary

MeasureTime frameDescription
Abdominal pain scores as measured by the Gastrointestinal Symptom Rating Scale - IBS.7 daysRetrospective measurements with a recall period of one week.
Symptom scores (other than abdominal pain) as measured using the ESM-tool.7 daysGastrointestinal symptoms, psychological symptoms, extra-intestinal symptoms, data on context and environment.
Gastrointestinal symptom scores (other than abdominal pain) as measured using the end-of-day diary.7 days
Abdominal pain scores as measured by the end-of-day diary.7 daysRetrospective measurements with a recall period of one day.
Psychological symptom scores as measured using the PHQ-9.7 days
Psychological symptom scores as measured using the GAD-7.7 days
Quality of life scores as measured using SF-36.7 days
Gastrointestinal symptom scores (other than abdominal pain) as measured using the GSRS-IBS.7 days

Countries

Netherlands

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026